期刊
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
卷 288, 期 6, 页码 L1026-L1032出版社
AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajplung.00354.2004
关键词
acute lung injury; endothelial; microarrays
资金
- NHLBI NIH HHS [HL-58064, HL-71411, HL-69340, HL-66583] Funding Source: Medline
Therapies to limit the life- threatening vascular leak observed in patients with acute lung injury (ALI) are currently lacking. We explored the effect of simvastatin, a 3-hydroxy-3-methylglutaryl ( HMG)-CoA reductase inhibitor that mediates endothelial cell barrier protection in vitro, in a murine inflammatory model of ALI. C57BL/6J mice were treated with simvastatin (5 or 20 mg/ kg body wt via intraperitoneal injection) 24 h before and again concomitantly with intratracheally administered LPS (2 mu g/ g body wt). Inflammatory indexes [bronchoalveolar lavage (BAL) myeloperoxidase activity and total neutrophil counts assessed at 24 h with histological confirmation] were markedly increased after LPS alone but significantly reduced in mice that also received simvastatin (20 mg/ kg; similar to 35 - 60% reduction). Simvastatin also decreased BAL albumin (similar to 50% reduction) and Evans blue albumin dye extravasation into lung tissue ( 100%) consistent with barrier protection. Finally, the sustained nature of simvastatin-mediated lung protection was assessed by analysis of simvastatin-induced gene expression (Affymetrix platform). LPS-mediated lung gene expression was significantly modulated by simvastatin within a number of gene ontologies ( e. g., inflammation and immune response, NF-kappa B regulation) and with respect to individual genes implicated in the development or severity of ALI (e. g., IL-6, Toll-like receptor 4). Together, these findings confirm significant protection by simvastatin on LPS- induced lung vascular leak and inflammation and implicate a potential role for statins in the management of ALI.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据